Results 31 to 40 of about 5,422,838 (209)

Neisseria meningitidis IgA1-specific serine protease exhibits novel cleavage activity against IgG3

Virulence, 2021
Neisseria meningitidis (meningococcus) is a common bacterial colonizer of the human nasopharynx but can occasionally cause very severe systemic infections with rapid onset.
Christian Spoerry, Jens Karlsson, Marie-Stephanie Aschtgen, Edmund Loh   +3 more
doaj   +1 more source

Invasive Meningococcal Disease in the Vaccine Era [PDF]

Frontiers in Pediatrics, 2018
Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. Humans are the only natural reservoir for the meningococcus which is found primarily as a commensal inhabitant in the nasopharynx in ~10% of adults, and may be found in over 25% of individuals during adolescence.
Simon Nadel, Nelly Ninis
openaire   +3 more sources

Meningococcal and pneumococcal meningitis in Northern Ghana [PDF]

, 2008
Despite improvements in technology, treatments and understanding of how bacterial meningitis develops, the disease remains a potentially life-threatening emergency capable of causing significant morbidity and mortality. N. meningitidis, S.
Forgor, Abdulai Adams
core   +1 more source

A case of invasive meningococcal disease presenting as myopericarditis

Clinical Infection in Practice, 2021
Background: Neisseria meningitidis is a universally-feared Gram negative diplococcus, and infection confers high rates of morbidity and mortality despite effective antimicrobial therapy.
Simon M. Durkin, Clemency Britton, Graham S. Cooke, Ravi Mehta   +3 more
doaj   +1 more source

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Heuberger, S., Stuart, J.M., G. HANQUET, Nielsen, Stine, Stefanoff, P., P. STEFANOFF, Hanquet, G, Hanquet, Germaine, S. HEUBERGER, Nielsen, S, J. M. STUART, W. HELLENBRAND, Stefanoff, P, Stuart, JM, Hellenbrand, Wiebke, Heuberger, S, S. NIELSEN, Hellenbrand, W, Hanquet, G.   +18 more
core   +1 more source

Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice

Microorganisms, 2020
The description of invasive meningococcal disease that is provoked by Neisseria meningitidis (Nm) is frequently restricted to meningitis. However, a wide panel of clinical presentations can be encountered including severe forms with intense inflammatory ...
Michael Levy, Myriam Aouiti Trabelsi, Muhamed-Kheir Taha   +2 more
doaj   +1 more source

Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature

BMC Infectious Diseases, 2021
Background SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is associated with various complications. PMA (primary meningococcal arthritis) is a rare meningococcus-associated disease causing arthritis of the knee usually, without ...
Norman Ducatez, Marine Chancel, Youcef Douadi, Charles Dayen, Rémi Suguenot, Emmanuelle Lecuyer, Benoit Brihaye, Houcine Bentayeb   +7 more
doaj   +1 more source

Sibling familial risk ratio of meningococcal disease in UK Caucasians. [PDF]

, 2003
To quantify the host genetic component of meningococcal disease (MD) susceptibility, the sibling risk ratio (lambdaS) was calculated as the ratio of observed MD cases among 845 siblings of 443 UK Caucasian cases to that expected, calculated from age ...
Haralambous, E, Hibberd, ML, Levin, M, Weiss, HA, Radalowicz, A, Booy, R   +5 more
core   +1 more source

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Human Vaccines & Immunotherapeutics, 2021
Invasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years.
Helen S. Marshall, Prabha H. Andraweera, Bing Wang, Mark McMillan, Ann P. Koehler, Noel Lally, Sara Almond, Emma Denehy, Michele A’Houre, Lynne C. Giles, Louise Flood   +10 more
doaj   +1 more source

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]

, 2015
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M, Ngadoua, C, Kadidja Gamougam, Dominique A. Caugant, Trotter, Caroline L, Toralta, J, Greenwood, B M, Ngadoua, Cyriaque, Fermon, Florence, Manigart, Olivier, Daugla, D M, Olivier Manigart, Daugla, Doumagoum M, Florence Fermon, Page, A-L, Caugant, D A, Djingarey, M H, Doumagoum M. Daugla, Fermon, F, James M. Stuart, Page, Anne-Laure, Trotter, C L, Caugant, Dominique A, Djingarey, Mamoudou H, Anne-Laure Page, Mamoudou Djingarey, Gamougam, Kadidja, Cyriaque Ngadoua, Toralta, Jacques, Stuart, J M, Stuart, James M, Gamougam, K, Manigart, O, Caroline L. Trotter, Jacques Toralta, Brian M. Greenwood   +35 more
core   +1 more source